Johnson & Johnson Raises 2026 Sales Guidance After $2.59 EPS

Johnson & Johnson posted third-quarter non-GAAP earnings per share of $2.59, exceeding expectations by 6 cents as revenue increased 5.8% from a year earlier.

Revenue reached $25.4 billion for the quarter, in line with expectations. The results included the company’s latest quarterly sales performance and adjusted per-share earnings.

Johnson & Johnson also raised its 2026 reported-sales outlook to $101.2 billion at the midpoint. The updated outlook represents 7.4% growth at the midpoint.